Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sara Małgorzata Orłowska has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Trans Fatty Acid Isomers: Health, Technological, and Regulatory Perspectives for Sustainable Fat Reformulation

    by Małgorzata Katarzyna Kowalska, José Luis Guil-Guerrero, Łukasz Bednarczyk, Piotr Jan Lubojański, Sara Małgorzata Orłowska, Joanna Elżbieta Lubojańska, Weronika Hudecka

    For decades, industrial trans fatty acids (iTFAs) have remained a critical focus of the scientific community, the food industry, and regulatory authorities because of their well-established role in the development of cardiovascular diseases, metabolic disorders, and chronic systemic inflammation. Rather than providing a descriptive overview, this review critically synthesizes current evidence on the elimination of industrial TFAs by integrating health, technological, regulatory, and sustainability perspectives into a comprehensive interdisciplinary analysis. The review outlines the biochemical characteristics and dietary sources of trans fatty acid isomers, highlighting the continuing scientific debate regarding the differential health effects of industrially produced and naturally occurring ruminant-derived TFAs. It also examines the evolution of scientific evidence that led to major regulatory actions by international organizations, including the World Health Organization (WHO) and the European Commission, resulting in legally binding restrictions that have substantially reduced industrial TFA intake and improved public health. Particular emphasis is placed on the critical assessment of current fat reformulation strategies, considering not only their technological functionality but also their nutritional quality, long-term metabolic implications, and contribution to sustainable food systems. Full hydrogenation, fractionation, chemical and enzymatic interesterification, and oleogelation are comparatively evaluated with respect to their advantages, limitations, and potential technological, nutritional, and environmental trade-offs. In addition, lipid microencapsulation is discussed as an emerging strategy for protecting oxidation-sensitive polyunsaturated fatty acids (PUFAs), thereby facilitating their incorporation into functional foods while maintaining nutritional quality. Unlike previous reviews that primarily focus on health outcomes or individual processing technologies, this review systematically integrates the sustainability dimensions of alternative fat modification approaches, including resource efficiency, energy consumption, clean label product development, and circular economy principles. Furthermore, it identifies current knowledge gaps related to the long-term metabolic safety, industrial scalability, and environmental performance of emerging lipid technologies. By combining these complementary perspectives, the review provides a comprehensive interdisciplinary synthesis that supports evidence-based fat reformulation and offers practical guidance for researchers, food manufacturers, and policy makers seeking to develop safer, nutritionally improved, technologically functional, and environmentally sustainable lipid systems.

  • Open Access

    Breast Cancer: Characteristics, Diagnostic and Therapeutic Options and the Potential of Nanoparticle Applications

    by Ahmed El-Mallul, Małgorzata Katarzyna Kowalska, Karolina Sawicka, Sara Małgorzata Orłowska, Łukasz Bednarczyk, Łucja Radziszewska

    Breast cancer is one of the most commonly diagnosed malignant tumors worldwide and represents a significant public health problem. This paper presents the characteristics of the disease, with particular emphasis on risk factors, mechanisms of development, and molecular classification. Current diagnostic methods and available therapeutic strategies, such as surgery, chemotherapy (CT), radiotherapy (RT), and targeted therapies, are discussed. Particular attention is given to nanotechnology as a promising direction for the development of modern medicine. The potential applications of nanoparticles (NPs) in the diagnosis and treatment of breast cancer are presented, taking into account their mechanisms of action, potential clinical benefits, and limitations related to safety and efficacy. NPs may contribute to increased diagnostic precision and therapeutic efficacy, indicating their significant potential in the future of oncology.

  • Open Access

    Vogt–Koyanagi–Harada Syndrome: Clinical Features, Immunogenetic Predisposition and PD-1 Inhibitor-Induced Forms—A Comprehensive Review

    by Sara Małgorzata Orłowska, Łukasz Bednarczyk, Kamal Morshed, Mateusz Tyniec, Paweł Olczyk

    Vogt–Koyanagi–Harada syndrome (VKH) is a rare granulomatous autoimmune disease characterised by a systemic immune response directed against melanocytes. This multisystem condition primarily affects organs that are rich in melanocytes, such as the eyes, inner ear, meninges and skin. VKH might be responsible for the development of chronic uveitis and permanent visual impairment, particularly in cases where a diagnosis is delayed and treatment is not administered in a timely manner. A key factor in its pathogenesis is the loss of immune tolerance to melanocytes, driven by a T-cell–mediated immune response and genetic susceptibility, including the presence of HLA-DRB1*04 antigens. In recent years, immune checkpoint inhibitors (ICIs) have become the standard treatment in oncology, including non-small cell lung cancer and unresectable melanoma. However, it should be noted that their utilisation carries with it the potential for immune-related adverse events, including rare cases of VKH-like uveitis. The objective of this review is to outline the clinical features of VKH syndrome, examine current diagnostic and treatment approaches, and emphasise the immunopathological mechanisms associated with drug-induced forms of VKH, with a particular focus on programmed cell death protein 1 (PD-1) inhibitors. The article also includes an analysis of the genetic, epigenetic, and environmental factors that predispose individuals to the disease. This analysis facilitates a deeper understanding of the pathogenesis of the disease and assists in the identification of patients at increased risk of drug-induced VKH manifestations.


  • Open Access

    The Multifaceted Nature of GLP-1: Molecular Mechanisms and Signaling Pathways in Metabolic and Neurodegenerative Diseases

    by Małgorzata Katarzyna Kowalska, Ahmed El-Mallul, Weronika Hudecka, Joanna Elżbieta Lubojańska, Piotr Jan Lubojański, Sara Małgorzata Orłowska, Łukasz Bednarczyk

    The aim of this article is to present the current state of knowledge regarding the use of GLP-1 agonists in the treatment of type 2 diabetes, obesity, and other potential clinical indications, including neurodegenerative conditions. The article describes the characteristics of the diseases discussed, with particular emphasis on the pathophysiological mechanisms and the impact of metabolic disorders on the course of the diseases. In addition, the specific role of GLP-1 receptor agonists and their mechanisms of action leading to improved clinical outcomes were discussed, including their impact on molecular pathways involved in glucose metabolism regulation, inflammatory processes, carcinogenesis, and neuroprotection. Based on meta-analyses of available clinical trials, the evidence supporting the effectiveness of GLP-1 agonist therapy in glycemic control, weight loss, and improvement of metabolic parameters was synthesized. Additionally, potential benefits beyond the metabolic system are discussed, including neuroprotective effects and impact on patients’ cardiovascular profiles, as well as risks and adverse effects associated with the use of GLP-1 agonists. The collected data indicate the growing role of GLP-1 agonists as an innovative and effective therapeutic strategy, while emphasizing the need for further research in the context of new clinical indications.


  • Open Access

    Pyogenic liver abscess in an obese adolescent without classical risk factors: a case report suggesting a possible metabolic association and successful conservative management

    by Łukasz Bednarczyk, Sara Małgorzata Orłowska, Cezary Dubaj

    Pediatric liver abscess is an uncommon but potentially serious disease entity, most frequently observed in children from developing countries or in patients with classical risk factors such as malnutrition, immunosuppression, or a history of abdominal surgery. However, emerging evidence suggests that obesity may represent a potential contributing factor. We present a case of a 16-year-old obese male (BMI 30.08 kg/m²) admitted with a 7-day history of high fever and right upper quadrant pain. Multimodal imaging (ultrasound, computed tomography, and magnetic resonance imaging) revealed a large (110 mm), multilocular, encapsulated lesion in the right hepatic lobe, initially mimicking a hydatid cyst (Echinococcosis). Stool PCR detected Clostridioides difficile and enteropathogenic Escherichia coli, which may suggest the involvement of intestinal barrier disorders in the development of the infection. The patient was successfully managed with broad-spectrum intravenous antibiotics (imipenem), followed by oral therapy (ciprofloxacin, metronidazole), and empirical albendazole. In stable pediatric patients presenting with atypical multilocular liver lesions, a conservative “safety-first” approach may be justified when parasitic etiology cannot be confidently excluded. Although classical predisposing factors were absent, significant obesity in our patient may represent a modern metabolic risk factor contributing to susceptibility to pyogenic liver abscess. These findings support a potential shift in the risk profile of pediatric liver abscess toward obesity-associated immune dysregulation. Keywords: pediatric liver abscess obesity immunometabolism fever of unknown origin magnetic resonance imaging abdominal pain

  • Open Access

    Obstructive sleep apnoea in children – clinical presentation, diagnosis, treatment

    by Maria Ochwat, Oliwia Osiak, Anna Piecha, Jagoda Pawlak, Sara Orłowska, Łukasz Bednarczyk, Maja Pękala, Katarzyna Niedziółka, Michał Oborski

    Introduction and purposeThe diagnosis of OSA in children is based on clinical symptoms and polysomnography (Apnea-Hypopnea Index ≥1 or hypoventilation). The ICSD-3 (International Classification of Sleep Disorders - Third Edition) guidelines are also utilized. Diagnostics are supported by pulse oximetry, lateral nasopharyngeal X-ray, cephalometry, fiberoptic endoscopy, and magnetic resonance imaging of the upper respiratory tract. OSA is associated with serious complications, including behavioral disorders, cardiovascular complications, metabolic disorders, and growth disturbances. Children with OSA also experience learning difficulties and lower school performance. Treatment includes adenotonsillectomy, CPAP/BiPAP therapy, surgical procedures, weight reduction, and pharmacotherapy. The effectiveness of treatment may be limited, particularly in obese children. Post-treatment monitoring of patients is necessary due to the risk of residual symptoms. Material and methodsThe literature available in Pubmed and Google Scholar databases was conducted using the key words. ResultsData indicate that OSA occurs in approx. 5% of children, especially during the preschool years and adolescence. Symptoms include loud snoring, respiratory pauses, behavioral disorders, school difficulties, and daytime sleepiness. Polysomnography remains the cornerstone of diagnosis, supported by the PSQ and modified STOP-BANG questionnaires. Untreated OSA leads to metabolic, cardiovascular, and neurobehavioral complications. Treatment includes adenotonsillectomy, PAP therapy, weight reduction, pharmacotherapy, and orthodontic management. Conclusions Obstructive sleep apnea in children is a disorder with significant health consequences, requiring prompt diagnosis and tailored treatment. Adenotonsillectomy is the primary treatment method, with additional therapies applied to patients with persistent symptoms or contraindications to surgery.


  • Open Access

    Molecular Basis, Diagnostic Approaches, and Therapeutic Strategies in Colorectal Cancer—Comprehensive Review

    by Małgorzata Katarzyna Kowalska, Ahmed El-Mallul, Joanna Elżbieta Lubojańska, Weronika Hudecka, Sara Małgorzata Orłowska, Piotr Jan Lubojański, Łukasz Bednarczyk

    This review covers issues related to the characteristics, diagnosis, and treatment of colorectal cancer (CRC). It discusses traditional methods of treating colorectal cancer, including surgery, chemotherapy, and radiotherapy, as well as modern approaches, including targeted therapies, immunotherapy, and innovative gene therapy strategies. Particular attention is paid to the identification of molecular subtypes of CRC, which has revolutionized treatment in advanced stages of the disease and contributed to improved patient survival. The role of biomarkers, including liquid biopsy, in diagnosis, therapy monitoring, and treatment response assessment is emphasized. The potential of artificial intelligence in planning and optimizing surgical procedures is also discussed, opening up new possibilities in personalized therapy. This article provides up-to-date knowledge on the molecular mechanisms of CRC, diagnostic prospects, and directions for the development of precision therapies, serving as a valuable source of information for both clinicians involved in the treatment of CRC and patients wishing to deepen their knowledge of the disease and modern therapeutic options.


  • Open Access

    Pathogenesis of Psoriasis vulgaris and Current Management and Therapeutic Strategies Including the Role of Emollients—A Review of the Current Literature

    by Małgorzata Katarzyna Kowalska, Sara Małgorzata Orłowska, Łukasz Bednarczyk, Joanna Elżbieta Majewska, Weronika Hudecka

    Psoriasis is a chronic inflammatory skin disease with a complex clinical picture that remains incurable and requires ongoing dermatological care. The purpose of this literature review is to identify the latest therapeutic strategies used to treat psoriasis, taking into account both the efficacy of modern approaches and their impact on patients’ quality of life. The cornerstone of psoriasis treatment remains regular skin care through the use of emollients, which support the effectiveness of other topical therapies used such as corticosteroids. In addition, the review presents current epidemiological data on the prevalence of psoriasis worldwide, with a focus on European countries and Poland. The article discusses innovative approaches in therapy, including targeted biologics, modern forms of topical therapy, and the role of emollients in comprehensive skin care, as well as various cosmetological treatments aimed at removing the excessively accumulated stratum corneum, and improving the degree of hydration of psoriatic skin. The review also included current expert recommendations and guidelines from scientific societies that guide the treatment and care of psoriatic skin. The results of the analyses underscore the need for targeted therapies and the importance of a holistic approach to patient care. As the collected data indicate, the possibilities for effective topical and systemic treatment of psoriasis are increasing all the time due to research into newer and newer active substances that are expected to improve the efficacy of treatment, the comfort of life for psoriasis patients and reduce the side effects of long-term therapy.


  • Open Access

    Applied Research on Atopic Dermatitis with Special Emphasis on the Role of Emollients in This Disorder: A Review

    by Małgorzata Katarzyna Kowalska, Sara Małgorzata Orłowska, Łukasz Bednarczyk

    Atopic dermatitis is a chronic and multifactorial inflammatory dermatosis. Recurrent eczematous lesions and intense pruritus very often reduce the quality of life of patients, affecting their mental health. For this reason, it is necessary to undertake treatment. Treatment should be characterized by an individual approach to the patient, taking into account the predominant pathogenetic factors in the development of atopic dermatitis and systematic skin care. Soothing the typical symptoms of AD, i.e., dry skin and persistent itching, involves emollients, which counteract xerosis and reduce the feeling of itching. Studies confirm that the regular use of emollients in patients with AD prolongs the period between relapses and alleviates the intensity of symptoms during periods of disease severity. This review paper aims to highlight the challenges that patients with atopic dermatitis face. This work will also present an indication of the rationale for the use of emollients in this condition, as well as an indication of the forms of their application in therapeutic and care preparations.